Global Robotic Neurosurgery Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Robotic Systems, Services, and Instruments & Accessories), By Application (Spinal Neurosurgery and Cranial Neurosurgery), By End User (Hospitals and Ambulatory Surgical Centers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare

RELEASE DATE Nov 2025
REPORT ID SI16369
PAGES 244
REPORT FORMAT PathSoft

Global Robotic Neurosurgery Market Insights Forecasts to 2035

  • The Global Robotic Neurosurgery Market Size Was Estimated at USD 0.395 Billion in 2024
  • The Market Size is Expected to Grow at a CAGR of around 15.65% from 2025 to 2035
  • The Worldwide Robotic Neurosurgery Market Size is Expected to Reach USD 1.955 Billion by 2035
  • Asia Pacific is expected to grow the fastest during the forecast period.

 

Get more details on this report -

Request Free Sample PDF

 

According to a research report published by Spherical Insights and Consulting, the global Robotic Neurosurgery market size was worth around USD 0.395 Billion in 2024 and is predicted to grow to around USD 1.955 Billion by 2035 with a compound annual growth rate (CAGR) of 15.65% from 2025 and 2035. The market for robotic neurosurgery has a number of opportunities to grow due to the growing integration of surgical robots in ambulatory surgical centers, driven by the prospect of shorter hospital stays, less healthcare expenditure, and high patient throughput.

 

Market Overview

The Robotic Neurosurgery Market Size is the global industry for technology that uses robotic systems to assist surgeons in performing intricate procedures on the brain, spine, and nervous system. Robotic neurosurgery includes the use of advanced surgical tools, resulting in advantages compared to traditional surgeries, like higher accuracy and dexterity enhancement. An increased demand for high precision for surgeries in the central nervous system with pathology of millimetres via small working channels around vital tissue, contributing to driving the demand for robotic neurosurgery.

 

Innovation and market expansion are anticipated as a result of major players' growing R&D expenditures and the expanding partnerships. For instance, in April 2025, Point Robotics MedTech Inc. officially signed a business cooperation agreement with U.S.-based spinal implant supplier CTLA (CTL America) through its wholly owned subsidiary in Singapore. The surging advancements like AI-driven automation, nanorobots, and 5G connectivity in remote surgery are driving a huge surge in the global robotic neurosurgery market.    

 

Report Coverage

This research report categorizes the Robotic Neurosurgery market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Robotic Neurosurgery market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the robotic neurosurgery market. 

 

Global Robotic Neurosurgery Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 0.395 Billion
Forecast Period:2024 – 2035
Forecast Period CAGR 2024 – 2035 :CAGR of 15.65%
024 – 2035 Value Projection:USD 1.955 Billion
Historical Data for:2020-2023
No. of Pages:244
Tables, Charts & Figures:100
Segments covered:By Product Type, By Application
Companies covered::Brainlab AG, Renishaw plc, Zimmer Biomet Holding, Inc., Medical Microinstruments, Inc., Monteris Medical Corporation, Medtronic plc., Globus Medical Inc., Accuray Incorporated, And Others Players, and
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The robotic neurosurgery market is primarily driven by an increasing prevalence of neurological conditions, which causes demand for advanced surgical interventions. For instance, in 2021, 3.4 billion people experienced a nervous system condition, as per the major new analysis from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2021, published in The Lancet Neurology journal. The inclination towards strategic alliances for promoting the adoption of AI-assisted robotic surgery due to its improved accuracy and reduced complication rates, as compared to manual methods, is anticipated to propel the market growth. For instance, in October 2025, Monteris Medical and Symphony Robotics announced a strategic partnership to advance the use of robotics for brain ablation surgery.

 

Restraining Factors

The robotic neurosurgery market is restricted by the increased acquisition costs and the lack of a skilled workforce. Further, the strict rules and regulations associated with the launch and commercialization of robotic neurosurgery are challenging the market growth.

 

Market Segmentation

The robotic neurosurgery market share is classified into product type, application, and end user.   

  • The instruments & accessories segment dominated the market with a major share of about 51.5% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product type, the robotic neurosurgery market is divided into robotic systems, services, and instruments & accessories. Among these, the instruments & accessories segment dominated the market with a major share of about 51.5% in 2024 and is projected to grow at a substantial CAGR during the forecast period. The segment includes robotic arms, wristed instruments, surgical cameras, control consoles, and other specialized tools. For instance, Da Vinci Xi provides advanced instrumentation, vision, and features like Firefly fluorescence imaging and integrated table motion.

 

Get more details on this report -

Request Free Sample PDF

 

  • The spinal neurosurgery segment accounted for the largest share of over 73.5% in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the robotic neurosurgery market is divided into spinal neurosurgery and cranial neurosurgery. Among these, the spinal neurosurgery segment accounted for the largest share of over 73.5% in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Robot-assisted spine surgery aids in enhancing the accuracy of pedicle screw placement and decreasing the radiation exposure to surgeons. For instance, the SpineAssist device is FDA-approved for spinal instrumentation. An increasing awareness about spine illnesses, along with an increase in the number of spine surgeries, is contributing to driving the market in the spinal neurosurgery segment.

 

  •   The hospitals segment accounted for the largest share of over 91.0% in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end user, the robotic neurosurgery market is divided into hospitals and ambulatory surgical centers. Among these, the hospitals segment accounted for the largest share of over 91.0% in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Hospitals provide a comprehensive range of services, making them a preferable choice for robotic surgery procedures. For instance, HCA Florida Kendall Hospital, a 424-bed facility and part of HCA Florida Healthcare, has performed its first robotic transforaminal lumbar interbody fusion, or TLIF—a major leap forward for its expanding neurospine program. The growing demand for complex neurosurgery procedures using robotic neurosurgery for improving surgical results and patient safety is driving the market demand in the hospitals segment.

 

Regional Segment Analysis of the Robotic Neurosurgery Market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the robotic neurosurgery market over the predicted timeframe.

North America is anticipated to hold the largest share of about 61.0% of the robotic neurosurgery market over the predicted timeframe. The market ecosystem in North America is strong, with both cutting-edge startups and major industrial heavyweights well-represented. For instance, in September 2025, UK startups join TMC to drive innovation in patient safety, maternal health, trauma, neurology, and surgery in U.S. The demand for robotic neurosurgery has been driven by the region's increasing advancements in robotics technology and the increasing prevalence of neurological disorders. The U.S. is dominating the North America robotic neurosurgery market in 2024, owing to the adoption of AR-based surgical navigation systems that provide real-time guidance during the surgery.

 

Asia Pacific is expected to grow at a rapid CAGR of approximately 20.3% in the robotic neurosurgery market during the forecast period. The Asia Pacific area has a thriving market for robotic neurosurgery due to an increasing demand for sophisticated and accurate surgical techniques, with the growing popularity of minimally invasive procedures. Due to the implementation of various initiatives that support advanced robotic surgery programs, the market for robotic neurosurgery is growing. For instance, in August 2025, AIIMS-Raipur would revolutionize healthcare in Central India, inaugurating its state-of-the-art Robotic Surgery programme, which is marking a crucial step in making cutting-edge technology accessible to patients. China dominates the Asia Pacific robotic neurosurgery market with about 30% share in 2024, driven by the increasing prevalence of neurological diseases, the increasing elderly population, along with surging need for precision-oriented minimally invasive procedures.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the robotic neurosurgery market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Brainlab AG
  • Renishaw plc
  • Zimmer Biomet Holding, Inc.
  • Medical Microinstruments, Inc.
  • Monteris Medical Corporation
  • Medtronic plc.
  • Globus Medical Inc.
  • Accuray Incorporated
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs) 

 

Recent Development

  • In November 2025, IMPLANET, a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, announced the signing of a partnership agreement with 8i Robotics Inc.

 

  • In August 2025, the World Health Organization (WHO) and the Society of Robotic Surgery (SRS) signed a Memorandum of Understanding (MoU) to advance equitable access to virtual care and telesurgery.

 

  • In June 2025, Indian medtech start-up SS Innovations makes Nasdaq debut, marking its official entry into the global capital markets, signifying the company’s strategic growth and India’s rising prominence in delivering affordable, world-class medical technologies on a global stage.

 

  • In May 2025, Vicarious Surgical announced a new hospital collaboration, inked a deal with UMass Memorial Medical Center, intended to support the adoption and utilization of its robotic system.  

 

  • In March 2025, Brain Navi Biotechnology, a leading innovator in neurosurgical robotics, announced a strategic partnership with BenQ Medical Technology to introduce and commercialize the NeoTrac neurosurgical navigation robot in the Chinese market.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the robotic neurosurgery market based on the below-mentioned segments:  

 

Global Robotic Neurosurgery Market, By Product Type

  • Robotic Systems
  • Services
  • Instruments & Accessories

 

Global Robotic Neurosurgery Market, By Application

  • Spinal Neurosurgery
  • Cranial Neurosurgery

 

Global Robotic Neurosurgery Market, By End User

  • Hospitals
  • Ambulatory Surgical Centers

 

Global Robotic Neurosurgery Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions (FAQ)

  • 1. What is the market size of the robotic neurosurgery market?
    The global robotic neurosurgery market size is expected to grow from USD 0.395 Billion in 2024 to USD 1.955 Billion by 2035, at a CAGR of 15.65% during the forecast period 2025-2035.
  • 2. Which region holds the largest share of the robotic neurosurgery market?
    North America is anticipated to hold the largest share of the robotic neurosurgery market over the predicted timeframe.
  • 3. What is the forecasted CAGR of the Global Robotic neurosurgery Market from 2024 to 2035?
    The market is expected to grow at a CAGR of around 15.65% during the period 2024–2035.
  • 4. Who are the top companies operating in the Global Robotic neurosurgery Market?
    Key players include Brainlab AG, Renishaw plc, Zimmer Biomet Holding, Inc., Medical Microinstruments, Inc., Monteris Medical Corporation, Medtronic plc., Globus Medical Inc., and Accuray Incorporated.
  • 5. Can you provide company profiles for the leading robotic neurosurgery manufacturers?
    Yes. For example, Brainlab AG is a privately held German medical technology company headquartered in Munich, Bavaria, that develops software and hardware for radiotherapy and radiosurgery, and the surgical fields of neurosurgery and spine surgery. Renishaw plc is an engineering technology company that specializes in the creation of high-precision technology for metrology and healthcare, and the company product offerings include robotics products and other healthcare and neurological products.
  • 6. What are the main drivers of growth in the robotic neurosurgery market?
    The increasing prevalence of neurological conditions and the adoption of AI-assisted robotic surgery are major market growth drivers of the robotic neurosurgery market.
  • 7. What challenges are limiting the robotic neurosurgery market?
    Increased acquisition costs and the lack of a skilled workforce, as well as stringent rules & regulations, remain key restraints in the robotic neurosurgery market.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies